Delivery Order SPE2DB24D2003-SPE2DB25FXMT0
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $1,610.40 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100-count units). This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,262.11 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 70 mg capsules (100-count units). The award was made on September 3, 2025, under firm fixed pricing with an ultimate completion date of September 4, 2025. This non-set-aside, competitively awarded delivery order will be performed at the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,977.61 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100 count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order was issued under a child contract arrangement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,760.99 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (90-count). The contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Lisdexamfetamine 70 mg capsules (90-count units) under a firm fixed-price contract valued at $1,735.76. This is a non-set-aside award, meaning it was competitively awarded without restrictions. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lisdexamfetamine 50 mg capsules (100-count units) with a ceiling value of $2,853.60. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and represents performance at the contractor's Conshohocken, Pennsylvania location. The award was competitively awarded with no set-aside designation. This delivery order is executed under...
- The Defense Logistics Agency awarded a $7,043.59 delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 17, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $3,957.98 to AmerisourceBergen Drug Corp for Lisdexamfetamine 20 mg capsules (100 count) on September 8, 2025, with completion targeted for September 9, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be delivered to the vendor's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $8,166.54 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 20 mg capsules (100 count). This firm fixed-price delivery order, awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, was competitively awarded without set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $9,919.40 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 40 mg capsules (90-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award through open solicitation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXMT0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,253.14 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 70 mg capsules (90-count units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive pharmaceutical portfolio delivered through its DLA contracts includes brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for a controlled pharmaceutical compound reflects AmerisourceBergen's ongoing role in supplying essential medications to support Defense Health Agency and broader military healthcare requirements through its flexible global pharmaceutical support contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 9/16/25 |